Eli Lilly (LLY.US) plans to submit a biologics license application for Retatrutide to the U.S. Food and Drug Administration (FDA) in the first quarter of 2027.

Spot gold has just surpassed the $4410.00/oz mark, currently quoted at $4410.17/oz, up 0.79% on the day; COMEX gold futures main contract is currently quoted at $4466.50/oz, up 0.66% on the day.

Most European stock markets rose on Monday, after most major indexes declined last week, with only Germany’s DAX reaching a record high. The Europe Stoxx 600 index climbed 0.2%, led by technology and pharmaceutical stocks. SpaceX supplier STMicroelectronics gained 3%, while ASML and its smaller rival ASM International rose 2.35% and 2.7% respectively. Dutch pharmaceutical company Argenx led the gains, up about 7.7% after announcing positive clinical trial results. Germany’s DAX index and the UK

Spot platinum has just broken through the $1770.00/ounce mark, now quoted at $1770.10/ounce, up 1.24% on the day; main Nymex platinum futures are now quoted at $1780.0/ounce, up 1.31% on the day.

Analyst: Geopolitical risk premium reverting supports the rebound, but further upside is limited